Stolper Co Decreases Stock Position in CVS Health Co. (NYSE:CVS)

Stolper Co trimmed its position in shares of CVS Health Co. (NYSE:CVS) by 10.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 21,429 shares of the pharmacy operator’s stock after selling 2,438 shares during the quarter. Stolper Co’s holdings in CVS Health were worth $962,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health in the 3rd quarter valued at $25,000. Ridgewood Investments LLC increased its holdings in CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 450 shares during the last quarter. Livelsberger Financial Advisory acquired a new stake in CVS Health in the third quarter valued at $31,000. Legacy Investment Solutions LLC purchased a new stake in CVS Health during the 3rd quarter worth about $31,000. Finally, Reston Wealth Management LLC acquired a new position in shares of CVS Health during the 3rd quarter worth about $32,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of NYSE:CVS opened at $52.15 on Thursday. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The company has a 50-day moving average price of $51.68 and a 200 day moving average price of $56.44. The company has a market cap of $65.63 billion, a P/E ratio of 13.24, a PEG ratio of 0.72 and a beta of 0.59. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the previous year, the business earned $2.21 earnings per share. Research analysts predict that CVS Health Co. will post 5.22 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.10%. CVS Health’s dividend payout ratio is presently 67.51%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on CVS shares. Barclays cut their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research report on Thursday, November 7th. Royal Bank of Canada reduced their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. TD Cowen raised their price objective on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 25th. Finally, UBS Group raised their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $68.71.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.